Skip to main content

Biometry

Contributes to the rigor and reproducibility of cancer research through statistical consultation and mathematical modeling. Supports research in biostatistical methods and data analytics, machine learning, and artificial intelligence for cancer risk prediction and reduction.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Resources

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Berger, Vance, Ph.D. vance.berger@nih.gov 240-276-7142	5E628	Statistician \| Biometry
	Bowles, Heather, Ph.D. heather.bowles@nih.gov 240-276-6794	5E640	Program Officer \| Biometry Cancer Prevention Fellowship Program
	Dodd, Kevin, Ph.D. kevin_dodd@nih.gov 240-276-7021	5E126	Deputy Chief \| Biometry
	Hu, Ping, Sc.D. ping.hu@nih.gov 240-276-7015	5E118	Statistician \| Biometry
	Morris, Lawrence lawrence.morris@nih.gov 240-276-7137	5E112	Program Specialist \| Biometry
	Prorok, Philip C, Ph.D. [C] philip.prorok@nih.gov 240-276-7131		Contractor \| Office of the Director Biometry
	Sirota, Lev, Ph.D. [C] lev.sirota@nih.gov 240-276-5127	5E114	Contractor \| Biometry
	Uzzell, Norwood norwood.uzzell@nih.gov 240-276-7141	5E222	Program Support Assistant \| Biometry
	Xu, Jian-Lun, Ph.D. jian-lun.xu@nih.gov 240-276-7023	5E128	Statistician \| Biometry

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Hecht, Stephen S	University Of Minnesota United States	High resolution mass spectrometric profile analysis of carcinogen-DNA adducts in oral cells of cigarette smokers and squamous cell carcinoma of the head and neck	5R01CA263084-05	Wendy Wang, Ph.D., M.Sc.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	5U01CA200464-08	Guillermo Marquez, Ph.D.
Herman, James G.	University Of Pittsburgh At Pittsburgh United States	Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies	5U2CCA271885-04	Wendy Wang, Ph.D., M.Sc.
Herrmann, Joerg	Mayo Clinic Rochester United States	TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) Trial	5R01CA233610-06	Eileen Dimond, R.N., M.S.
Hilakivi-Clarke, Leena A.	University Of Minnesota United States	Effect of maternal obesity on breast cancer among offspring: role of the gut microbiota	5R01CA276775-03	Amit Kumar, Ph.D.
Hill, Joshua Aiden	Fred Hutchinson Cancer Center United States	Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy	5R01CA276040-03	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Hitchins, Megan P	H. Lee Moffitt Cancer Ctr & Res Inst United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	7R01CA252042-05	Matthew Young, Ph.D.
Hollingsworth, Michael A.	University Of Nebraska Medical Center United States	Pancreatic Cancer Detection Consortium	5U01CA210240-09	Matthew Young, Ph.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Therapeutic modulation of a proteomic HCC risk signature with statins in patients with liver cirrhosis	4U01CA288375-03	Sidney Fu, M.D.
Houghton, A Mcgarry	Fred Hutchinson Cancer Center United States	Tumor-specific autoantibodies for SCLC early detection	5R01CA243328-06	Guillermo Marquez, Ph.D.
Howitt, Brooke E	Stanford University United States	Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping	1R37CA303960-01	Goli Samimi, Ph.D., M.P.H.
Hruska, Carrie B	Mayo Clinic Rochester United States	Density MATTERS Clinical Trial	5R01CA239200-05	Claire Zhu, Ph.D.
Hsu, Li	Fred Hutchinson Cancer Center United States	Statistical Methods for Precision Prevention	1R01CA297681-01	Claire Zhu, Ph.D.
Hu, Shuiying	Ohio State University United States	Targeting neuronal transport to ameliorate vincristine neurotoxicity	5R01CA272254-03	Rachel Altshuler, Ph.D.
Hu, Jim	Weill Medical Coll Of Cornell Univ United States	Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)	5R01CA259173-04	Marjorie Perloff, M.D.